跳至主要内容
临床试验/NCT07634146
NCT07634146尚未招募不适用

A Randomized, Sham Supplement- and Care-as-Usual-Controlled Study to Evaluate Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study

Miracle Wellness LLC1 个研究点 分布在 1 个国家目标入组 920 人开始时间: 2026年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
920
试验地点
1

研究概览

简要总结

The purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Self-reported history of migraine, based on the International Headache Society (IHS) International Classification of Headache Disorders, 3rd edition (ICHD-3) diagnostic criteria for migraine.
  • Being able to take oral supplements.
  • Agreeing to maintain their regular lifestyle.
  • Access to internet and telephone.

排除标准

  • Pregnancy or lactation.
  • Presence of any active medical condition or diagnosis other than episodic migraine, including liver or kidney disease or condition.
  • Use of overlapping supplements or interacting medications.
  • Known allergies to study ingredients.
  • Daily use of alcohol, tobacco, or recreational drugs.
  • Participation in any other clinical or interventional study within 30 days prior to baseline or concurrently.

研究者

发起方
Miracle Wellness LLC
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验